ALS News Today21h
Dosing begins in Phase 1 trial of potential ALS therapy RAG-17
A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.
ALS News Today4d
Muscle mass biomarker is associated with risk of developing ALS: Study
The creatinine-to-cystatin C ratio may indicate the risk of developing amyotrophic lateral sclerosis, a large-scale database ...
ALS News Today3d
A Former Coach Living With ALS Gives Back to the Community
This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for US audiences only. Any other ...
ALS News Today3d
Diabetes, high cholesterol linked with lower risk of developing ALS
Despite the lower ALS risk, heart and metabolism problems are tied to faster disease progression and worse survival in the ...
ALS News Today8d
Top 10 ALS news stories of 2024
Throughout 2024, ALS News Today brought our readers daily coverage of the latest in scientific breakthroughs, treatment advances, and clinical trial updates related to amyotrophic lateral sclerosis ...
ALS News Today4d
Finding moments of warmth during the winter of ALS
Columnist Kristin Neva is applying something she learned about finding moments to appreciate during winter to life with ALS.
ALS News Today6d
Why I named my column ‘Living Well with ALS’
Columnist Dagmar Munn offers an explainer to highlight the deeper meaning behind the title her column, "Living Well with ALS." ...